SEC Filing · EFFECT
BridgeBio Oncology Therapeutics, Inc.
BBOTNASDAQEQUITYCurrent
SEC Filing
Company context
Helix Acquisition Corp. II (Nasdaq: HLXB) is a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. Helix Acquisition Corp. II raised $184 million in its initial public offering on February 9, 2024. Helix is sponsored by affiliates of Cormorant Asset Management and is headquartered in Boston, Massachusetts.
Current securities
Document unavailable
This filing is not currently available in the archive. Read it on SEC EDGAR ↗